Organovo Holdings Inc., a San Diego-based 3D bioprinting firm, announced that Chief Financial Officer Barry Michaels will retire at the end of the fiscal year in March. The company will launch an immediate search for his replacement.

Michaels, whose career spans nearly 40 years, has been with Organovo since 2011. He previously served as CFO of three private and three publicly traded companies, including Cardima Inc., Lipid Sciences Inc. and ICN Biomedicals Inc. He also served as an independent consultant to medical device and biotechnology companies. He is a graduate of San Diego State University and the University of California, Los Angeles.

“As part of the leadership team, Barry has been instrumental in Organovo’s transition from a startup R&D company into the publicly traded, growing product development company we are today," said CEO Keith Murphy. " His many contributions have better positioned the company for sustainable growth and success.“